BioCentury
ARTICLE | Clinical News

ALD-451: Phase I started

July 23, 2012 7:00 AM UTC

Cytomedix said that Duke University Medical Center (Durham, N.C.) began an open-label, U.S. Phase I trial to evaluate IV ALD-451 following surgery, radiation and temozolomide in up to 12 patients with...